BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop ...

Holdings announced the date of effectiveness and the ratio of a forthcoming reverse stock split of the Company’s Common Stock. On January 13, 2025, the Company announced, on a Current Report on Form 8 ...

BioXcel Therapeutics (BTAI) announced that it will effect a 1-for-16 reverse stock split of its common stock. The reverse stock split will ...

(RTTNews) - BioXcel Therapeutics, Inc. (BTAI), Thursday announced a reverse stock split of 1-for-16 to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq ...

Mullen Automotive Inc. (NASDAQ:MULN), a player in the motor vehicles and passenger car bodies industry, conducted a Special Meeting of Stockholders where key decisions were made regarding the ...

Al-Baha Investment and Development Co.said its post-reverse stock split share capital will be 218.30 million, instead of 2.18 ...

BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a pharmaceutical company with a market capitalization of $14.83 million, announced today the implementation of a 1-for-16 reverse stock split of its common ...

Bakkt stock price surged on speculation of a buyout by Trump's DJT. Check out why I downgraded my Hold rating on BKKT stock ...

Nexxen International reiterated the timeline and process for its upcoming stock exchange and trading structure changes on ...

Electric-truck maker Nikola is nearing filing for a bankruptcy, the Wall Street Journal reported on Thursday, citing people ...

Wexford-based biopharmaceutical company Coeptis announced that it had closed on a $5.7 million addition to its preferred ...

K SEC filing received on January 31, 2025, that the company has been notified by The Nasdaq Stock Market, LLC about its failure to meet the minimum bid requirement for continued listing on the Nasdaq ...